IGFBP3 and non-small cell lung carcinoma: Given the antiproliferative, proapoptotic, antiangiogenic, and anti-adhesion effects of IGFBP-3 in a variety of cancer cells [20,21,64], we postulated the antimetastatic activity of IGFBP-3 in NSCLC and HNSCC.